Table 4 The relations between depression dimensional profilers’ scores and metabolic-inflammatory impairments
|
Atypical, energy-related symptom dimension (0–15) Median scores (%) |
Melancholic symptom dimension (0–24) Median scores (%) |
Childhood trauma symptom dimension (0–8) Median scores (%) |
Anxious distress symptom dimension (0–15) Median scores (%) | Test of significance | |
|---|---|---|---|---|---|
|
Hypertensive patients (n = 41) | 12.3 (82%) | 9.2 (38.3%) | 3.3 (41.2%) | 8.1 (54%) | p < 0.001* |
|
Impaired glycemic control (n = 36) | 12.9 (86%) | 7.4 (30.8%) | 2.6 (32.5%) | 11.7 (78%) | p < 0.001* |
|
Elevated LDL/HDL ratio (n = 64) | 11.8 (78.6%) | 10.1 (42%) | 3.1 (38.7%) | 6.8 (45.3%) | p = 0.038* |
|
Elevated TGS (n = 61) | 12.1 (80.6%) | 8.9 (37%) | 3.7 (46.2%) | 6.4 (42.6%) | p = 0.026* |
|
Central obesity (n = 57) | 13 (86.6%) | 9 (37.5%) | 3 (37.5%) | 6 (40%) | p = 0.004* |
|
Elevated CRP (n = 34) | 9.2 (61.3%) | 11.3 (47%) | 6.8 (85%) | 7.3 (48.6%) | p= .009* |